Carnation Industries Q2FY27: Profit back at ₹0.53 cr
Ask Iris
What changed in the September quarter
Carnation Industries Limited reported a return to profit in Q2FY27, helped by revenue from operations after a nil base in the year-ago quarter. The company posted net profit of ₹0.53 crore for the quarter ended September 30, 2026. This marked a clear reversal from the loss reported in Q1FY27.
The update matters because it combines three signals investors typically track in small-cap turnarounds: a swing in bottom line, the reappearance of operating revenue, and continuing pressure from finance costs. The Board of Directors approved the unaudited results on October 15, 2026.
Q2FY27 headline numbers: revenue returns, profit turns positive
For Q2FY27, revenue from operations came in at ₹1.01 crore. The company also reported a profit before tax (PBT) of ₹0.55 crore for the quarter, showing a sharp improvement from Q1FY27.
Carnation’s Q2FY27 net profit of ₹0.53 crore compares with a Q1FY27 net loss of ₹0.52 crore (as shown in the reported quarterly snapshot). The company also indicated that Q2FY26 had nil revenue from operations, making Q2FY27 a meaningful change on the top line.
Finance costs stayed high relative to operating performance
A key detail in the update was the continued weight of finance costs. Finance costs were ₹0.35 crore in Q2FY27, which the company noted was higher than the pre-tax operating profit of ₹0.05 crore.
This gap is important because it shows that while the quarter ended with positive profit, interest and related charges remain a major line item. With finance costs exceeding the quarter’s pre-tax operating profit, the quality and durability of earnings will likely remain linked to how funding costs evolve and how stable operating revenue becomes.
Board approval and audit review report: what was flagged
The company said the Board approved the unaudited financial results on October 15, 2026. The statutory auditors, Jain Saraogi & Co LLP, issued a review report that included observations.
Those observations referred to procedural delays in regulatory filings and unclaimed dividends. The note is relevant for shareholders because it points to compliance and process issues rather than a dispute over the reported numbers. The disclosures did not quantify the unclaimed dividends in the provided information.
Profit before tax trend across quarters and FY26
Carnation’s PBT improved sequentially and also showed a better comparison against the year-ago quarter. As per the provided financial table, PBT stood at ₹0.55 crore in Q2FY27 versus a loss of ₹0.50 crore in Q1FY27, and a loss of ₹0.26 crore in Q2FY26. FY26 PBT was ₹0.27 crore.
While the company’s Q2FY27 revenue and profit figures show improvement, the presence of high finance costs and the small base of operating revenue mean investors will likely watch subsequent quarters closely for consistency.
Strategic developments: name change and registered office shift
Alongside the quarterly result context, the update also referenced strategic corporate changes. Shareholders have approved a name change to “Ebravea Beverages Limited”.
The company also indicated a shift of the registered office from West Bengal to Delhi. These changes are typically treated as material corporate actions because they may signal a change in corporate focus, administrative base, or future business direction, although no additional operational detail was provided in the supplied text.
AGM voting: near-unanimous support for resolutions
Carnation Industries said it received near-unanimous shareholder approval at its annual general meeting held on August 26, 2026, with 99.98% support for all agenda items mentioned.
Key resolutions passed included adoption of the audited financial statements for FY26, the reappointment of Ms. Bhawna Gupta as a director retiring by rotation, approval of related-party transactions under Section 188 of the Companies Act, 2013, and amendment to the object clause of the memorandum of association.
Corporate calendar: board meeting and results flow
The filings and calendar entries included a board meeting intimation that the board would meet on October 15, 2026 to consider and approve the September quarter unaudited financial results. Separately, a corporate actions table listed a board meeting dated Oct 14, 2026 (announced on Oct 11, 2026) with the stated purpose of quarterly results.
The company also appeared in a list of firms expected to announce Q2 results on the day, alongside other companies. The provided text did not include the company’s stock price move on the results date.
Key numbers table (all amounts in ₹ crore)
Other disclosed items investors may track
The supplied text also referenced a Reuters item dated May 26 noting that Carnation Industries approved a rights issue of equity shares for up to ₹50 crore. The excerpt did not provide additional terms such as price, ratio, or timelines.
Separately, FY25-26 (as filed) was shown with revenue of ₹1.70 crore and net profit of -₹0.13 crore, along with an EPS of -₹0.38. These annual figures provide context that profitability has been uneven, even as the latest quarter shows a return to profit.
Market impact and why the details matter
The Q2FY27 update presents a mixed but clearer picture: operating revenue was reported at ₹1.01 crore versus nil in the year-ago quarter, and bottom line turned positive at ₹0.53 crore. But finance costs at ₹0.35 crore were highlighted as exceeding pre-tax operating profit of ₹0.05 crore, indicating that financing structure and cost of funds remain central to results.
From a governance and process perspective, the auditors’ observations on procedural delays in regulatory filings and unclaimed dividends are also relevant. At the same time, shareholder approvals for the name change to Ebravea Beverages Limited, the registered office shift from West Bengal to Delhi, and the AGM resolutions indicate active corporate actions underway.
Conclusion
Carnation Industries’ Q2FY27 results showed a turnaround, with ₹0.53 crore net profit on ₹1.01 crore revenue and a PBT of ₹0.55 crore. The company’s board approved the unaudited results on October 15, 2026, while the auditors noted procedural delays in filings and unclaimed dividends. Next, investors will track follow-up disclosures around the approved name change and registered office shift, and any further detail on the referenced rights issue.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q2 Earnings Tracker